Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > 9 more sites

<< Previous

Bullboard Posts

Next >>

Comment by enriquesuaveon Jan 03, 2023 11:30pm

353 Views

Post# 35202009

RE:RE:RE:RE:9 more sites

I just checked and see that Endocyte buyout happened in Oct. 2018 and the drug approval was 3.5 years later in March of 2022. If we get AA, then a good chance we get bought out with an approved drug and while 3 PH1 trials are in place, GBM, NSCLC and COVID.. $2.1 Billion will be cheap. IMHO

<< Previous

Bullboard Posts

Next >>

Mastering options Greeks: Essential knowledge for informed trading